Properties (55)
Predicate | Object |
---|---|
gptkbp:instanceOf |
topical medication
|
gptkbp:activeDuring |
minoxidil
|
gptkbp:availability |
widely available in pharmacies
|
gptkbp:availableIn |
over-the-counter
|
gptkbp:brand |
gptkb:Rogaine
|
gptkbp:clinicalTrials |
Phase III
not recommended for children consult doctor if using other medications not for use in pregnant women proven effective for androgenetic alopecia treatment of female pattern hair loss treatment of male pattern baldness |
gptkbp:colors |
white
|
gptkbp:communityFeedback |
mixed results
|
gptkbp:contraindication |
headache
rash shortness of breath scalp conditions heart palpitations allergy to minoxidil swelling of hands or feet |
gptkbp:dosageForm |
topical foam
|
gptkbp:duration |
at least 4 months for results
|
gptkbp:evaluates |
varies by individual
|
gptkbp:formulation |
foam
|
gptkbp:hasMuseum |
safe for most users
|
https://www.w3.org/2000/01/rdf-schema#label |
Rogaine Foam
|
gptkbp:impact |
ongoing for maintenance
|
gptkbp:lastProduced |
1988
|
gptkbp:launchSite |
applied to the scalp
|
gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
gptkbp:marketedAs |
gptkb:Rogaine
|
gptkbp:packaging |
aerosol can
|
gptkbp:patentStatus |
patented
|
gptkbp:patentType |
yes
|
gptkbp:priceRange |
varies by retailer
|
gptkbp:regulatoryCompliance |
approved_by_FDA
|
gptkbp:safetyFeatures |
generally well tolerated
|
gptkbp:sideEffect |
dizziness
chest pain weight gain scalp irritation unwanted facial hair growth |
gptkbp:storage |
room temperature
|
gptkbp:suitableFor |
twice daily
|
gptkbp:targets |
men and women
|
gptkbp:texture |
light and non-greasy
|
gptkbp:triggerType |
vasodilator
|
gptkbp:trimLevels |
neutral
|
gptkbp:type |
minoxidil foam
|
gptkbp:usedFor |
hair loss
|
gptkbp:uses |
avoid contact with eyes
apply to dry scalp wash hands after use do not rinse after application |